ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2018

Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release.

Ryan T Hurt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.